David A Sallman (David Sallman)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 53

Top Topics

Acute Myeloid Leukemia

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

American journal of hematology

Blood cancer journal

This page only lists publications with an associated author ORCID identifier.

Publications

Cristina Astrid Tentori, Caterina Gregorio, Marie Robin, Nico Gagelmann, Carmelo Gurnari, Somedeb Ball, Juan Carlos Caballero-Berrocal, Luca Lanino, Saverio D'Amico, Marta Spreafico, Giulia Maggioni, Erica Travaglino, Elisabetta Sauta, Manja Meggendorfer, Lin-Pierre Zhao, Alessia Campagna, null null, Victor Savevski, Armando Santoro, Najla Al Ali, David A Sallman, Francisco Solé, Guillermo Garcia Manero, Ulrich Germing, Nicolaus Kröger, Shahram Kordasti, Valeria Santini, Guillermo F Sanz, Wolfgang Kern, Uwe Platzbecker, Maria Diez Campelo, Jaroslaw P Maciejewski, Lionel Ades, Pierre Fenaux, Torsten Haferlach, Amer M Zeidan, Gastone C Castellani, Rami S Komrokji, Francesca Ieva, Matteo Giovanni Della Porta, null null
Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (24) (2024)
Courtney D D DiNardo, Gail J Roboz, Justin M Watts, Yazan F Madanat, Gabrielle T Prince, Praneeth Baratam, Stéphane de Botton, Anthony S Stein, James M Foran, Martha L Arellano, David A Sallman, Mohammad Hossain, Dylan M Marchione, Xiaofei Bai, Prapti A Patel, Stephanie M Kapsalis, Guillermo Garcia-Manero, Amir T Fathi
Final phase I substudy results of ivosidenib in patients with mutant IDH1 relapsed/refractory myelodysplastic syndrome. Blood advances (2024)
Courtney D D DiNardo, Gail J Roboz, Justin M Watts, Yazan F Madanat, Gabrielle T Prince, Praneeth Baratam, Stéphane de Botton, Anthony S Stein, James M Foran, Martha L Arellano, David A Sallman, Mohammad Hossain, Dylan M Marchione, Xiaofei Bai, Prapti A Patel, Stephanie M Kapsalis, Guillermo Garcia-Manero, Amir T Fathi
Final phase I substudy results of ivosidenib in patients with mutant IDH1 relapsed/refractory myelodysplastic syndrome. Blood advances (2024)
Onyee Chan, Najla Al Ali, Hammad Tashkandi, Austin Ellis, Somedeb Ball, Justin Grenet, Caroline Hana, Yehuda Deutsch, Ling Zhang, Mohammad Hussaini, Jinming Song, Seongseok Yun, Chetasi Talati, Andrew T Kuykendall, Eric Padron, Alison Walker, Gail J Roboz, Pinkal Desai, David A Sallman, Kendra Sweet, Rami S Komrokji, Jeffrey Lancet
Mutations highly specific for secondary AML are associated with poor outcomes in ELN favorable risk NPM1-mutated AML. Blood advances 8 (5) (2024)
Onyee Chan, Najla H Al Ali, Hammad Tashkandi, Austin Ellis, Somedeb Ball, Justin Grenet, Caroline Hana, Yehuda Deutsch, Ling Zhang, Mohammad O Hussaini, Jinming Song, Seongseok Yun, Chetasi Talati, Andrew T Kuykendall, Eric Padron, Alison R Walker, Gail J Roboz, Pinkal Desai, David A Sallman, Kendra L Sweet, Rami S Komrokji, Jeffrey E Lancet
Mutations Highly Specific for Secondary AML are Associated with Poor Outcomes in ELN Favorable Risk NPM1-mutated AML. Blood advances (2024)
Nana Adjoa Ben-Crentsil, Wazim Mohammed Ismail, Maria E Balasis, Hannah Newman, Ariel Quintana, Moritz Binder, Traci Kruer, Surendra Neupane, Meghan C Ferrall-Fairbanks, Jenna Fernandez, Terra L Lasho, Christy M Finke, Mohammed L Ibrahim, Kathy L McGraw, Michael Wysota, Amy L Aldrich, Christopher B Ryder, Christopher T Letson, Joshua Traina, Amy F McLemore, Nathalie M Droin, Aditi Shastri, Seongseok Yun, Eric Solary, David A Sallman, Amer A Beg, Li Ma, Alexandre Gaspar-Maia, Mirinal S Patnaik, Eric Padron
RNA shielding of P65 is required to potentiate oncogenic inflammation in TET2 mutated clonal hematopoiesis. Cancer discovery (2024)
Onyee Chan, Najla Al Ali, Hammad Tashkandi, Austin Ellis, Somedeb Ball, Justin Grenet, Caroline Hana, Yehuda Deutsch, Ling Zhang, Mohammad Hussaini, Jinming Song, Seongseok Yun, Chetasi Talati, Andrew T Kuykendall, Eric Padron, Alison Walker, Gail J Roboz, Pinkal Desai, David A Sallman, Kendra Sweet, Rami S Komrokji, Jeffrey Lancet
Mutations highly specific for secondary AML are associated with poor outcomes in ELN favorable risk NPM1-mutated AML. Blood advances 8 (5) (2024)
Cristina Astrid Tentori, Caterina Gregorio, Marie Robin, Nico Gagelmann, Carmelo Gurnari, Somedeb Ball, Juan Carlos Caballero-Berrocal, Luca Lanino, Saverio D'Amico, Marta Spreafico, Giulia Maggioni, Erica Travaglino, Elisabetta Sauta, Manja Meggendorfer, Lin-Pierre Zhao, Alessia Campagna, null null, Victor Savevski, Armando Santoro, Najla Al Ali, David A Sallman, Francisco Solé, Guillermo Garcia Manero, Ulrich Germing, Nicolaus Kröger, Shahram Kordasti, Valeria Santini, Guillermo F Sanz, Wolfgang Kern, Uwe Platzbecker, Maria Diez Campelo, Jaroslaw P Maciejewski, Lionel Ades, Pierre Fenaux, Torsten Haferlach, Amer M Zeidan, Gastone C Castellani, Rami S Komrokji, Francesca Ieva, Matteo Giovanni Della Porta, null null
Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (24) (2024)
Sylvain Garciaz, Pierre-Yves Dumas, Sarah Bertoli, David A Sallman, Justine Decroocq, Amine Belhabri, Corentin Orvain, Gaspar Aspas Requena, Celestine Simand, Kamel Laribi, Martin Carré, Alberto Santagostino, Chantal Himberlin, Pierre Peterlin, Sarah Bonnet, Onyee Chan, Jeffrey E Lancet, Rami Komrokji, François Vergez, Nicolas Chapuis, Tatiana Raskovalova, Adriana Plesa, Anne-Catherine Lhoumeau, Ariane Mineur, Marie Anne Hospital, Arnaud Pigneux, Norbert Vey, Christian Recher
Outcomes of acute myeloid leukemia patients who responded to venetoclax and azacitidine and stopped treatment. American journal of hematology (2024)
Cristina Astrid Tentori, Caterina Gregorio, Marie Robin, Nico Gagelmann, Carmelo Gurnari, Somedeb Ball, Juan Carlos Caballero-Berrocal, Luca Lanino, Saverio D'Amico, Marta Spreafico, Giulia Maggioni, Erica Travaglino, Elisabetta Sauta, Manja Meggendorfer, Lin-Pierre Zhao, Alessia Campagna, null null, Victor Savevski, Armando Santoro, Najla Al Ali, David A Sallman, Francisco Solé, Guillermo Garcia Manero, Ulrich Germing, Nicolaus Kröger, Shahram Kordasti, Valeria Santini, Guillermo F Sanz, Wolfgang Kern, Uwe Platzbecker, Maria Diez Campelo, Jaroslaw P Maciejewski, Lionel Ades, Pierre Fenaux, Torsten Haferlach, Amer M Zeidan, Gastone C Castellani, Rami S Komrokji, Francesca Ieva, Matteo Giovanni Della Porta, null null
Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (24) (2024)
Courtney D D DiNardo, Gail J Roboz, Justin M Watts, Yazan F Madanat, Gabrielle T Prince, Praneeth Baratam, Stéphane de Botton, Anthony Stein, James M Foran, Martha L Arellano, David A Sallman, Mohammad Hossain, Dylan M Marchione, Xiaofei Bai, Prapti A Patel, Stephanie M Kapsalis, Guillermo Garcia-Manero, Amir T Fathi
Final phase 1 substudy results of ivosidenib for patients with mutant IDH1 relapsed/refractory myelodysplastic syndrome. Blood advances 8 (15) (2024)
Sylvain Garciaz, Pierre-Yves Dumas, Sarah Bertoli, David A Sallman, Justine Decroocq, Amine Belhabri, Corentin Orvain, Gaspar Aspas Requena, Celestine Simand, Kamel Laribi, Martin Carré, Alberto Santagostino, Chantal Himberlin, Pierre Peterlin, Sarah Bonnet, Onyee Chan, Jeffrey E Lancet, Rami Komrokji, François Vergez, Nicolas Chapuis, Tatiana Raskovalova, Adriana Plesa, Anne-Catherine Lhoumeau, Ariane Mineur, Marie Anne Hospital, Arnaud Pigneux, Norbert Vey, Christian Recher
Outcomes of acute myeloid leukemia patients who responded to venetoclax and azacitidine and stopped treatment. American journal of hematology (2024)
Courtney D D DiNardo, Gail J Roboz, Justin M Watts, Yazan F Madanat, Gabrielle T Prince, Praneeth Baratam, Stéphane de Botton, Anthony Stein, James M Foran, Martha L Arellano, David A Sallman, Mohammad Hossain, Dylan M Marchione, Xiaofei Bai, Prapti A Patel, Stephanie M Kapsalis, Guillermo Garcia-Manero, Amir T Fathi
Final phase 1 substudy results of ivosidenib for patients with mutant IDH1 relapsed/refractory myelodysplastic syndrome. Blood advances 8 (15) (2024)
Cristina Astrid Tentori, Caterina Gregorio, Marie Robin, Nico Gagelmann, Carmelo Gurnari, Somedeb Ball, Juan Carlos Caballero-Berrocal, Luca Lanino, Saverio D'Amico, Marta Spreafico, Giulia Maggioni, Erica Travaglino, Elisabetta Sauta, Manja Meggendorfer, Lin-Pierre Zhao, Alessia Campagna, null null, Victor Savevski, Armando Santoro, Najla Al Ali, David A Sallman, Francisco Solé, Guillermo Garcia Manero, Ulrich Germing, Nicolaus Kröger, Shahram Kordasti, Valeria Santini, Guillermo F Sanz, Wolfgang Kern, Uwe Platzbecker, Maria Diez Campelo, Jaroslaw P Maciejewski, Lionel Ades, Pierre Fenaux, Torsten Haferlach, Amer M Zeidan, Gastone C Castellani, Rami S Komrokji, Francesca Ieva, Matteo Giovanni Della Porta
Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
David A Sallman, Maximilian Stahl
TP53-Mutated Acute Myeloid Leukemia: How Can We Improve Outcomes? Blood (2024)
Dana E Rollison, Brian D Gonzalez, Kea Turner, Heather S L Jim, Yayi Zhao, Rossybelle P Amorrortu, Rachel Howard, Kavita M Ghia, Bryan Ngo, Phillip Reisman, Colin Moore, Randa Perkins, Robert J Keenan, David A Sallman, Cristina M Naso, Edmondo J Robinson, Susan T Vadaparampil, Vani N Simmons, Matthew B Schabath, Scott M Gilbert
Examining disparities in large-scale patient-reported data capture using digital tools among cancer patients at clinical intake. Cancer medicine (2023)
Parth C Patel, Somedeb Ball, Akriti Gupta Jain, Chen Wang, Mohammad O Hussaini, Luis E Aguirre, Onyee Chan, Seongseok Yun, Andrew T Kuykendall, Eric Padron, Kendra L Sweet, Jeffrey E Lancet, Rami S Komrokji, David A Sallman
Drivers of deep molecular response and long-term outcomes in patients with core binding factor acute myeloid leukemia. American journal of hematology (2023)
Qianxing Mo, Seongseok Yun, David A Sallman, Nicole D Vincelette, Guang Peng, Ling Zhang, Jeffrey E Lancet, Eric Padron
Integrative molecular subtypes of acute myeloid leukemia. Blood cancer journal 13 (1) (2023)
Farah Fleti, Onyee Chan, Amritpal Singh, Maymona G Abdelmagid, Aref A Al-Kali, Michelle A Elliott, Kebede H Begna, James M Foran, Talha Badar, Nandita Khera, Najla H Al Ali, Eric Padron, David A Sallman, Mithun Vinod Shah, Devendra K Hiwase, Animesh D Pardanani, Daniel A Arber, Attilio Orazi, Kaaren K Reichard, Rong He, Rhett P Ketterling, Naseema Gangat, Rami S Komrokji, Ayalew Tefferi
TP53 mutations and variant allele frequency in myelodysplastic syndromes with del(5q): a Mayo-Moffitt study of 156 informative cases. American journal of hematology (2023)
Qianxing Mo, Seongseok Yun, David A Sallman, Nicole D Vincelette, Guang Peng, Ling Zhang, Jeffrey E Lancet, Eric Padron
Integrative molecular subtypes of acute myeloid leukemia. Blood cancer journal 13 (1) (2023)
Farah Fleti, Onyee Chan, Amritpal Singh, Maymona G Abdelmagid, Aref A Al-Kali, Michelle A Elliott, Kebede H Begna, James M Foran, Talha Badar, Nandita Khera, Najla H Al Ali, Eric Padron, David A Sallman, Mithun Vinod Shah, Devendra K Hiwase, Animesh D Pardanani, Daniel A Arber, Attilio Orazi, Kaaren K Reichard, Rong He, Rhett P Ketterling, Naseema Gangat, Rami S Komrokji, Ayalew Tefferi
TP53 mutations and variant allele frequency in myelodysplastic syndromes with del(5q): A Mayo-Moffitt study of 156 informative cases. American journal of hematology (2023)
Naval G Daver, Paresh Vyas, Suman Kambhampati, Monzr M Al Malki, Richard A Larson, Adam S Asch, Gabriel Mannis, Wanxing Chai-Ho, Tiffany N Tanaka, Terrence J Bradley, Deepa Jeyakumar, Eunice S Wang, Kendra Sweet, Hagop M Kantarjian, Guillermo Garcia Manero, Rami S Komrokji, Guan Xing, Giridharan Ramsingh, Camille Renard, Joshua F Zeidner, David A Sallman
Tolerability and Efficacy of the Anticluster of Differentiation 47 Antibody Magrolimab Combined With Azacitidine in Patients With Previously Untreated AML: Phase Ib Results. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Ayalew Tefferi, Farah Fleti, Onyee Chan, Najla H Al Ali, Aref A Al-Kali, Kebede H Begna, James M Foran, Talha Badar, Nandita Khera, Mithun Vinod Shah, Devendra K Hiwase, Eric Padron, David A Sallman, Animesh D Pardanani, Daniel A Arber, Attilio Orazi, Kaaren K Reichard, Rong He, Rhett P Ketterling, Naseema Gangat, Rami S Komrokji
TP53 variant allele frequency and therapy-related setting independently predict survival in myelodysplastic syndromes with del(5q). British journal of haematology (2023)
David A Sallman, Monzr M Al Malki, Adam S Asch, Eunice S Wang, Joseph G Jurcic, Terrence J Bradley, Ian W Flinn, Daniel A Pollyea, Suman Kambhampati, Tiffany N Tanaka, Joshua F Zeidner, Guillermo Garcia Manero, Deepa Jeyakumar, Rami S Komrokji, Jeffrey Lancet, Hagop M Kantarjian, Lin Gu, Yajia Zhang, Anderson Tan, Mark Chao, Carol O'Hear, Giridharan Ramsingh, Indu Lal, Paresh Vyas, Naval G Daver
Magrolimab in Combination With Azacitidine in Patients With Higher-Risk Myelodysplastic Syndromes: Final Results of a Phase Ib Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Mark Gurney, Abhishek A Mangaonkar, Terra Lasho, Christy Finke, Aref A Al-Kali, Naseema Gangat, Mithun Vinod Shah, Hassan B Alkhateeb, Ayalew Tefferi, David A Sallman, Zhuoer Xie, David Viswanatha, Kaaren Reichard, Najla Al Ali, Rami S Komrokji, Eric Padron, Mirinal S Patnaik
Somatic TP53 single nucleotide variants, indels and copy number alterations in chronic myelomonocytic leukemia (CMML). Leukemia (2023)
Luis E Aguirre, Najla Al Ali, David A Sallman, Somedeb Ball, Akriti G Jain, Onyee Chan, Sara M Tinsley-Vance, Andrew Kuykendall, Kendra Sweet, Jeffrey E Lancet, Eric Padron, Rami S Komrokji
Assessment and validation of the molecular international prognostic scoring system for myelodysplastic syndromes. Leukemia (2023)
David A Sallman, Monzr M Al Malki, Adam S Asch, Eunice S Wang, Joseph G Jurcic, Terrence J Bradley, Ian W Flinn, Daniel A Pollyea, Suman Kambhampati, Tiffany N Tanaka, Joshua F Zeidner, Guillermo Garcia Manero, Deepa Jeyakumar, Rami S Komrokji, Jeffrey Lancet, Hagop M Kantarjian, Lin Gu, Yajia Zhang, Anderson Tan, Mark Chao, Carol O'Hear, Giridharan Ramsingh, Indu Lal, Paresh Vyas, Naval G Daver
Magrolimab in Combination With Azacitidine in Patients With Higher-Risk Myelodysplastic Syndromes: Final Results of a Phase Ib Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Farah Fleti, Onyee Chan, Amritpal Singh, Maymona G Abdelmagid, Aref A Al-Kali, Michelle A Elliott, Kebede H Begna, James M Foran, Talha Badar, Nandita Khera, Najla H Al Ali, Eric Padron, David A Sallman, Mithun Vinod Shah, Devendra K Hiwase, Animesh D Pardanani, Daniel A Arber, Attilio Orazi, Kaaren K Reichard, Rong He, Rhett P Ketterling, Naseema Gangat, Rami S Komrokji, Ayalew Tefferi
TP53 mutations and variant allele frequency in myelodysplastic syndromes with del(5q): A Mayo-Moffitt study of 156 informative cases. American journal of hematology 98 (4) (2023)
Qianxing Mo, Seongseok Yun, David A Sallman, Nicole D Vincelette, Guang Peng, Ling Zhang, Jeffrey E Lancet, Eric Padron
Integrative molecular subtypes of acute myeloid leukemia. Blood cancer journal 13 (1) (2023)
Christopher T Letson, Maria E Balasis, Hannah Newman, Moritz Binder, Alexis Vedder, Fumi Kinose, Markus Ball, Traci Kruer, Ariel Quintana, Terra L Lasho, Christy M Finke, Luciana L Almada, Jennifer Margaret Grants, Guolin Zhang, Martin E Fernandez-Zapico, Alexandre Gaspar-Maia, Jeffrey E Lancet, Rami S Komrokji, Eric B Haura, David A Sallman, Gary W Reuther, Aly Karsan, Uwe Rix, Mirinal S Patnaik, Eric Padron
Targeting BET proteins downregulates miR-33a to promote synergy with PIM inhibitors in CMML. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Farah Fleti, Onyee Chan, Amritpal Singh, Maymona G Abdelmagid, Aref A Al-Kali, Michelle A Elliott, Kebede H Begna, James M Foran, Talha Badar, Nandita Khera, Najla H Al Ali, Eric Padron, David A Sallman, Mithun Vinod Shah, Devendra K Hiwase, Animesh D Pardanani, Daniel A Arber, Attilio Orazi, Kaaren K Reichard, Rong He, Rhett P Ketterling, Naseema Gangat, Rami S Komrokji, Ayalew Tefferi
TP53 mutations and variant allele frequency in myelodysplastic syndromes with del(5q): A Mayo-Moffitt study of 156 informative cases. American journal of hematology 98 (4) (2023)
Qianxing Mo, Seongseok Yun, David A Sallman, Nicole D Vincelette, Guang Peng, Ling Zhang, Jeffrey E Lancet, Eric Padron
Integrative molecular subtypes of acute myeloid leukemia. Blood cancer journal 13 (1) (2023)
Farah Fleti, Onyee Chan, Amritpal Singh, Maymona G Abdelmagid, Aref A Al-Kali, Michelle A Elliott, Kebede H Begna, James M Foran, Talha Badar, Nandita Khera, Najla H Al Ali, Eric Padron, David A Sallman, Mithun Vinod Shah, Devendra K Hiwase, Animesh D Pardanani, Daniel A Arber, Attilio Orazi, Kaaren K Reichard, Rong He, Rhett P Ketterling, Naseema Gangat, Rami S Komrokji, Ayalew Tefferi
TP53 mutations and variant allele frequency in myelodysplastic syndromes with del(5q): A Mayo-Moffitt study of 156 informative cases. American journal of hematology 98 (4) (2023)
Mirinal S Patnaik, Amer M Zeidan, Eric Padron, Uwe Platzbecker, David A Sallman, Amy E DeZern, Rafael Bejar, Mikkael A Sekeres, Justin Taylor, Richard F Little, Jan P Bewersdorf, Tae Kon Kim, Nina Kim, Christopher S Hourigan, Matteo G Dela Porta, Maximilian Stahl, David Steensma, Mina L Xu, Olatoyosi Odenike, Hetty E Carraway, Pierre Fenaux, Aziz Nazha, Rami S Komrokji, Sanam Loghavi, Zhuoer Xie, Robert P Hasserjian, Michael R Savona, John M Bennett
Differences in classification schemata for myelodysplastic/myeloproliferative overlap neoplasms. Leukemia 36 (12) (2022)
Naval G Daver, Abhishek Maiti, Tapan Mahendra Kadia, Paresh Vyas, Ravindra Majeti, Andrew H Wei, Guillermo Garcia Manero, Charles F Craddock, David A Sallman, Hagop M Kantarjian
TP53-Mutated Myelodysplastic Syndrome and Acute Myeloid Leukemia: Biology, Current Therapy, and Future Directions. Cancer discovery 12 (11) (2022)
Abhishek A Mangaonkar, Terra L Lasho, Rhett P Ketterling, Kaaren K Reichard, Naseema Gangat, Aref A Al-Kali, Kebede H Begna, Animesh Pardanani, Najla H Al Ali, Chetasi Talati, David A Sallman, Eric Padron, Mirinal S Patnaik, Ayalew Tefferi, Rami S Komrokji
Myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T): Mayo-Moffitt collaborative study of 158 patients. Blood cancer journal 12 (2) (2022)
Rami S Komrokji, Avani M Singh, Najla Al Ali, Onyee Chan, Eric Padron, Kendra Sweet, Andrew Kuykendall, Jeffrey E Lancet, David A Sallman
Assessing the role of venetoclax in combination with hypomethylating agents in higher risk myelodysplastic syndrome. Blood cancer journal 12 (11) (2022)
Asmita Mishra, Roni Tamari, Amy E DeZern, Michael T Byrne, Mahasweta Gooptu, Yi-Bin Chen, H Joachim Deeg, David A Sallman, Phillip Gallacher, Anders Wennborg, Denice K Hickman, Eyal C Attar, Hugo F Fernandez
Eprenetapopt Plus Azacitidine After Allogeneic Hematopoietic Stem-Cell Transplantation for TP53 -Mutant Acute Myeloid Leukemia and Myelodysplastic Syndromes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (34) (2022)
Somedeb Ball, Akriti G Jain, Luis E Aguirre, Najla Al Ali, Yumeng Zhang, Onyee Chan, Andrew T Kuykendall, Kendra L Sweet, Jeffrey E Lancet, David M Swoboda, Eric Padron, Rami S Komrokji, David A Sallman
Hypomethylating agent and venetoclax in patients with chronic myelomonocytic leukemia: Is the combination indeed better? American journal of hematology 97 (5) (2022)
Andrew M Brunner, Alexander Gavralidis, Najla Al Ali, Anthony Hunter, Rami S Komrokji, Amer Zeidan, David A Sallman
Evaluating complete remission with partial hematologic recovery (CRh) as a response criterion in myelodysplastic syndromes (MDS). Blood cancer journal 12 (11) (2022)
David M Swoboda, Rashmi Kanagal-Shamana, Andrew M Brunner, Thomas Cluzeau, Onyee Chan, Najla Al Ali, Guillermo Montalban-Bravo, Quinto J Gesiotto, Alexander Gavralidis, Anthony M Hunter, Jung-Hoon Lee, Andrew T Kuykendall, Chetasi Talati, Kendra L Sweet, Jeffrey E Lancet, Eric Padron, Mohammad Hussaini, Jinming Song, Guillermo Garcia Manero, Rami S Komrokji, David A Sallman
Marrow ring sideroblasts are highly predictive for TP53 mutation in MDS with excess blasts. Leukemia 36 (4) (2022)
Amer M Zeidan, Jan Philipp Bewersdorf, Rena Buckstein, Mikkael A Sekeres, David P Steensma, Uwe Platzbecker, Sanam Loghavi, Jacqueline Boultwood, Rafael Bejar, John M Bennett, Uma Borate, Andrew M Brunner, Hetty E Carraway, Jane E Churpek, Naval G Daver, Matteo Della Porta, Amy E DeZern, Fabio Efficace, Pierre Fenaux, Maria E Figueroa, Peter Greenberg, Elizabeth A Griffiths, Stephanie Halene, Robert P Hasserjian, Christopher S Hourigan, Nina Kim, Tae Kon Kim, Rami S Komrokji, Vijay Kutchroo, Alan F List, Richard F Little, Ravindra Majeti, Aziz Nazha, Stephen D Nimer, Olatoyosi Odenike, Eric Padron, Mirinal S Patnaik, Gail J Roboz, David A Sallman, Guillermo F Sanz, Maximilian Stahl, Daniel T Starczynowski, Justin Taylor, Zhuoer Xie, Mina L Xu, Michael R Savona, Andrew H Wei, Omar Abdel-Wahab, Valeria Santini
Finding consistency in classifications of myeloid neoplasms: a perspective on behalf of the International Workshop for Myelodysplastic Syndromes. Leukemia 36 (12) (2022)
Kenji M Fujihara, Bonnie Z Zhang, Thomas D Jackson, Moses Olalekan Ogunkola, Brunda Nijagal, Julia V Milne, David A Sallman, Ching-Seng Ang, Iva Nikolic, Conor J Kearney, Simon J Hogg, Carlos S Cabalag, Vivien R Sutton, Sally Watt, Asuka T Fujihara, Joseph A Trapani, Kaylene J Simpson, Diana Stojanovski, Silke Leimkühler, Sue Haupt, Wayne A Phillips, Nicholas James Clemons
Eprenetapopt triggers ferroptosis, inhibits NFS1 cysteine desulfurase, and synergizes with serine and glycine dietary restriction. Science advances 8 (37) (2022)
Meghan C Ferrall-Fairbanks, Abhishek Dhawan, Brian Johnson, Hannah Newman, Virginia O Volpe, Christopher T Letson, Markus Ball, Anthony M Hunter, Maria E Balasis, Traci Kruer, Nana Adjoa Ben-Crentsil, Jodi L Kroeger, Robert Balderas, Rami S Komrokji, David A Sallman, Jing Zhang, Rafael Bejar, Philipp M Altrock, Eric Padron
Progenitor Hierarchy of Chronic Myelomonocytic Leukemia Identifies Inflammatory Monocytic-Biased Trajectory Linked to Worse Outcomes. Blood cancer discovery 3 (6) (2022)
Thomas Cluzeau, Marie Sebert, Ramy Rahmé, Stefania Cuzzubbo, Jacqueline Lehmann-Che, Isabelle Madelaine, Pierre Peterlin, Blandine Bève, Habiba Attalah, Fatiha Chermat, Elsa Miekoutima, Odile Beyne Rauzy, Christian Recher, Aspasia Stamatoullas, Lise Willems, Emmanuel Raffoux, Céline Berthon, Bruno Quesnel, Michael Loschi, Antoine F Carpentier, David A Sallman, Rami S Komrokji, Anouk Walter-Petrich, Sylvie Chevret, Lionel Ades, Pierre Fenaux
Eprenetapopt Plus Azacitidine in TP53-Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia: A Phase II Study by the Groupe Francophone des Myélodysplasies (GFM). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (14) (2021)
David A Sallman, Amy E DeZern, Guillermo Garcia Manero, David P Steensma, Gail J Roboz, Mikkael A Sekeres, Thomas Cluzeau, Kendra L Sweet, Amy F McLemore, Kathy L McGraw, John Puskas, Ling Zhang, Jiqiang Yao, Qianxing Mo, Lisa Nardelli, Najla H Al Ali, Eric Padron, Greg Korbel, Eyal C Attar, Hagop M Kantarjian, Jeffrey E Lancet, Pierre Fenaux, Alan F List, Rami S Komrokji
Eprenetapopt (APR-246) and Azacitidine in TP53-Mutant Myelodysplastic Syndromes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (14) (2021)
Rashmi Kanagal-Shamana, Guillermo Montalban-Bravo, Panagiotis Katsonis, Koji Sasaki, Caleb A Class, Elias Jabbour, David A Sallman, Anthony Michael Hunter, Christopher Benton, Kelly S Chien, Rajyalakshmi Luthra, Carlos E Bueso-Ramos, Tapan Mahendra Kadia, Michael Andreeff, Rami S Komrokji, Najla H Al Ali, Nicholas James Short, Naval G Daver, Mark J Routbort, Joseph D Khoury, Keyur Pravinchandra Patel, Irene Ganan-Gomez, Yue Wei, Gautam Borthakur, Farhad Ravandi, Kim-Anh Do, Kelly A Soltysiak, Olivier Lichtarge, L Jeffrey Medeiros, Hagop M Kantarjian, Guillermo Garcia Manero
Evolutionary action score identifies a subset of TP53 mutated myelodysplastic syndrome with favorable prognosis. Blood cancer journal 11 (3) (2021)
Aziz Nazha, Rami S Komrokji, Manja Meggendorfer, Xuefei Jia, Nathan Radakovich, Jacob Shreve, C Beau Hilton, Yasunubo Nagata, Betty K Hamilton, Sudipto Mukherjee, Najla Al Ali, Wencke Walter, Stephan Hutter, Eric Padron, David A Sallman, Teodora Kuzmanovic, Cassandra Kerr, Vera Adema, David P Steensma, Amy Dezern, Gail J Roboz, Guillermo Garcia Manero, Harry P Erba, Claudia Haferlach, Jaroslaw P Maciejewski, Torsten Haferlach, Mikkael A Sekeres
Personalized Prediction Model to Risk Stratify Patients With Myelodysplastic Syndromes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (33) (2021)
Rami S Komrokji, Najla H Al Ali, David A Sallman, Eric Padron, Amy E DeZern, John Barnard, Gail J Roboz, Guillermo Garcia-Manero, Alan List, David P Steensma, Mikkael A Sekeres
Validation of International Working Group response criteria in higher-risk myelodysplastic syndromes: A report on behalf of the MDS Clinical Research Consortium. Cancer medicine 10 (2) (2020)
David M Swoboda, Najla Al Ali, Onyee Chan, Eric Padron, Andrew T Kuykendall, Jinming Song, Mohammad Hussaini, Chetasi Talati, Kendra Sweet, Jeffrey E Lancet, David A Sallman, Rami S Komrokji
PTPN11 mutations are associated with poor outcomes across myeloid malignancies. Leukemia 35 (1) (2020)
Seongseok Yun, Susan M Geyer, Rami S Komrokji, Najla H Al Ali, Jinming Song, Mohammad Hussaini, Kendra L Sweet, Jeffrey E Lancet, Alan F List, Eric Padron, David A Sallman
Prognostic significance of serial molecular annotation in myelodysplastic syndromes (MDS) and secondary acute myeloid leukemia (sAML). Leukemia 35 (4) (2020)
David A Sallman, Alan F List
The central role of inflammatory signaling in the pathogenesis of myelodysplastic syndromes. Blood 133 (10) (2019)
Andrew T Kuykendall, Chetasi Talati, Eric Padron, Kendra L Sweet, Jeffrey E Lancet, Alan F List, David A Sallman, Rami S Komrokji
Driver mutation-specific clinical and genomic correlates differ between primary and secondary myelofibrosis. American journal of hematology 94 (12) (2019)